ADARB2
Summary: This gene encodes a member of the double-stranded RNA adenosine deaminase family of RNA-editing enzymes and may play a regulatory role in RNA editing. [provided by RefSeq, Jul 2008].
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
adenosine deaminase, RNA specific B2 (inactive) | MIM:602065 | Ensembl:ENSG00000185736 | HGNC:HGNC:227 | PA24557 | 10p15.3 |
GO terms in ADARB2
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
CC | IBA | GO:0005634 | nucleus |
CC | IEA | GO:0005634 | nucleus |
CC | IBA | GO:0005730 | nucleolus |
CC | IBA | GO:0005737 | cytoplasm |
BP | IBA | GO:0006382 | adenosine to inosine editing |
BP | IBA | GO:0006396 | RNA processing |
BP | IEA | GO:0006397 | mRNA processing |
MF | HDA | GO:0003723 | RNA binding |
MF | IBA | GO:0003725 | double-stranded RNA binding |
MF | TAS | GO:0003725 | double-stranded RNA binding |
MF | IBA | GO:0003726 | double-stranded RNA adenosine deaminase activity |
MF | TAS | GO:0003727 | single-stranded RNA binding |
MF | IEA | GO:0004000 | adenosine deaminase activity |
MF | IBA | GO:0008251 | tRNA-specific adenosine deaminase activity |
MF | IEA | GO:0046872 | metal ion binding |
Gene expression in normal tissue: ADARB2
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ADARB2
Database | Pathway ID | Pathway Des. |
---|
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD158 | NSC141540 | 2 |
iGMDRD481 | Dactolisib | 2 |
iGMDRD267 | Oligomycin A | 2 |
iGMDRD213 | SMR000068650 | 2 |
iGMDRD329 | Merck60 | 5 |
iGMDRD367 | Ro 28-1675 | 2 |
iGMDRD414 | MST-312 | 3 |
iGMDRD82 | Quiflapon | 2 |
iGMDRD512 | nutlin 3 | 3 |
iGMDRD701 | NVP-AUY922 | 2 |
iGMDRD150 | RITA | 3 |
iGMDRD532 | Olaparib | 3 |
iGMDRD424 | Tamatinib | 1 |
iGMDRD345 | Compound 10b [PMID: 11504634] | 2 |
iGMDRD901 | ELCPK | 3 |
iGMDRD177 | Teniposide | 2 |
iGMDRD255 | SB225002 | 2 |
iGMDRD270 | Ciclosporin | 2 |
iGMDRD801 | 2,4-dideoxy-DC-45-A2 | 2 |
iGMDRD52 | Rotenone | 2 |
iGMDRD782 | DC-45-A2 | 2 |
iGMDRD888 | Compound 44 | 1 |
iGMDRD562 | Navitoclax | 2 |
iGMDRD188 | Piperlongumine | 2 |
iGMDRD100 | Zebularine | 2 |
iGMDRD74 | Idarubicin | 2 |
iGMDRD730 | Kahalalide F | 3 |
iGMDRD887 | Compound 23 citrate | 2 |
iGMDRD64 | Parbendazole | 1 |
iGMDRD772 | BRD4770 | 3 |
iGMDRD579 | PF750 | 2 |
iGMDRD427 | ABT737 | 2 |
iGMDRD639 | YK 4-279 | 3 |
iGMDRD316 | N9-Isopropyl-olomoucine | 2 |
iGMDRD193 | Fqi1 | 2 |
iGMDRD446 | LY 2183240 | 2 |
iGMDRD201 | SKI II | 2 |
iGMDRD280 | CYTOCHALASIN B | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in ADARB2